Primary Hepatobiliary Cancer Cohort of Central China

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions
Hepatocellular CarcinomaBiliary Tract Neoplasms
Trial Locations (1)

430030

RECRUITING

Hepatic Surgery Center, Tongji Hospital, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
collaborator

Chinese Cooperative Group of Liver Cancer

OTHER

collaborator

Chen Xiao-ping Foundation for the Development of Science and Technology of Hubei Province

OTHER

collaborator

Haplox Biotechnology Co., Ltd.

INDUSTRY

collaborator

Geneplus-Beijing Co. Ltd.

INDUSTRY

collaborator

YuceBio Technology

UNKNOWN

collaborator

Gelesis, Inc.

INDUSTRY

lead

Tongji Hospital

OTHER

NCT05520801 - Primary Hepatobiliary Cancer Cohort of Central China | Biotech Hunter | Biotech Hunter